In The News
Reuters: WTO
delays decision on waiver on COVID-19 drug, vaccine rights
"World Trade Organization members on Thursday delayed a decision on a
proposal to waive intellectual property rules for COVID-19 drugs and
vaccines amid ongoing opposition from wealthy countries, a Geneva trade
official said. 'Big Pharma' has rejected an idea proposed by India and
South Africa that would grant compulsory licensing of the vaccines and
drugs by overriding patent rules of WTO's Trade-Related Aspects of
Intellectual Property (TRIPS) agreement, allowing generic or other
manufactures to make the new products. The proposal has won support from
some countries at the WTO but is opposed by Western countries, including
Britain, Switzerland, and the United States, which have strong domestic
pharmaceutical industries..." (Farge/Nebehay, 12/10).
AP: U.S. panel
endorses widespread use of Pfizer COVID-19 vaccine
"A U.S. government advisory panel endorsed widespread use of Pfizer's
coronavirus vaccine Thursday, putting the country just one step away from
launching an epic vaccination campaign against the outbreak that has killed
close to 300,000 Americans. Shots could begin within days, depending on how
quickly the Food and Drug Administration signs off, as expected, on the
expert committee's recommendation..." (Neergaard/Perrone, 12/10).
Financial Times:
U.S. offers to help increase production of Pfizer/BioNTech Covid vaccine
"The U.S. government is offering to help increase production of the
Pfizer/BioNTech Covid-19 vaccine, as it tries to secure another 100m doses
of the jab that regulators are reviewing. Operation Warp Speed, the
government program to accelerate the development of a vaccine, is trying to
double its pre-order of doses, after soaring demand has led to a shortage,
according to people familiar with the matter. Operation Warp Speed is
trying to help Pfizer obtain more raw materials and equipment under the
Defense Production Act to ensure it can produce the extra doses by June
2021, according to one of the people..." (Kuchler et al., 12/11).
POLITICO: U.S.
health officials say authorization is imminent for Pfizer coronavirus
vaccine
"...An independent FDA advisory committee on Thursday voted to
recommend use of the Pfizer vaccine for people aged 16 and older. The
panel's recommendation is nonbinding, but the agency's top vaccine official,
Peter Marks, has stated that the FDA could grant its blessing in a matter
of days. Marks issued a statement with FDA
Commissioner Stephen Hahn on Friday morning confirming Azar's announcement,
and saying that the agency 'will rapidly work toward finalization and
issuance of an emergency use authorization.' The two officials added that
they have also notified the Centers for Disease Control and Prevention and
the Trump administration's Operation Warp Speed, so that it can gear up for
the distribution effort..." (Niedzwiadek, 12/11).
STAT: The timeline
for Covid-19 vaccine distribution keeps slipping. Experts say it will
change again
"...The shifting timelines are already apparent with Covid-19 vaccine
distribution in the U.S. -- even before the rollout starts in the coming
days. The Trump administration declared in May that 300 million vaccine
doses would be available by January 2021, with the first distributed in
October of this year. By October, that had shifted to 100 million doses by
the end of the year, according to Health and Human Services Secretary Alex
Azar. Currently, the plan is for 40 million doses to be distributed in December,
though some in health care are skeptical of even that prediction..." (Goldhill,
12/11).
Additional coverage of the FDA advisory panel's
recommendation and speculation regarding the distribution of a new
coronavirus vaccine in the U.S. is available from The Atlantic, Financial Times, The Hill, New York Times, NPR, POLITICO, Science, STAT, and Washington Post.
AP: AP Interview:
India vaccine maker sees virus as wake-up call
"The coronavirus pandemic is a 'wake up call' for governments to
invest more in health care, says Adar Poonawalla, CEO of the Serum Institute
of India, the world's largest manufacturer of vaccines. The Serum Institute
has taken on a vital role as the largest company licensed to manufacture
the Oxford University-AstraZeneca coronavirus vaccine. It is increasing its
production capacity by the end of 2021 to over 2.5 billion doses a year to
cope with future disease outbreaks, Poonawalla said in a telephone
interview with the Associated Press..." (Ghosal, 12/11).
Quartz: Who is
using China's Covid-19 vaccines?
"...Before Britain granted emergency-authorization to the Pfizer
vaccine, a few countries had also used emergency approval to began offering
China's Covid-19 shots to health workers. Currently, four Covid-19 vaccines
from three Chinese firms are at an advanced stage: Sinopharm has two
vaccines in development; private U.S.-listed biotech firm Sinovac has
developed a shot called CoronaVac; and CanSino Biologics also has a
candidate..." (Lahiri, 12/10).
Washington Post:
Russia expected a surge for its Sputnik V vaccine. But many skeptics still
stayed away.
"...With Russia's coronavirus cases rising sharply, authorities are
banking on the country's Sputnik V vaccine as the answer to the crisis --
and opened the vaccine to the public even before it finishes Phase III
trials. In the first group, health workers and teachers can start the
two-dose treatment. But there seemed to be more vaccine skeptics than
takers in the first week across Russia, struggling with the fourth-highest number
of cases at more than 2.5 million..." (Dixon, 12/11).
Sydney Morning Herald:
Australian COVID vaccine terminated due to HIV 'false positives'
"A billion-dollar deal for the Morrison government to buy more than 50
million doses of the University of Queensland's potential coronavirus
vaccine has been abruptly terminated after several trial participants
returned false positive HIV test results..." (Harris, 12/11).
Wall Street Journal:
Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests
"A Covid-19 vaccine candidate in Australia has been scrapped because
recipients returned false positives on certain HIV tests, underscoring the
difficulties scientists face in rapidly developing an inoculation for the
coronavirus. The vaccine candidate, called v451, was being jointly
developed by the University of Queensland and CSL Ltd., an Australia-based
biopharma company that also runs blood-collection centers in the U.S. The
Australian government had agreed to buy 51 million doses..." (Cherney,
12/10).
Additional coverage of the decision to scrap the
vaccine is available from CNN, New York Times,
and Reuters.
Reuters: Sanofi
and GSK delay COVID-19 vaccine, marking setback for global fight
"Sanofi and GlaxoSmithKline said clinical trials of their COVID-19
vaccine showed an insufficient immune response in older people, delaying
its launch to late next year and marking a setback in the global fight
against the pandemic. ... The news, which came on the same day as Australia
axed a domestic vaccine project, is also a blow for many governments that
have booked hundreds of millions of doses of the shot, including the
European Union, United States, and Britain. ... The two companies said they
planned to start another study next February, hoping to come up with a more
effective vaccine by the end of 2021..." (Blamont et al., 12/11).
Additional coverage of the Sanofi/GSK vaccine candidate
is available from Financial Times.
Devex: ADB
launches $9B COVID-19 vaccine facility
"The Asian Development Bank launched a $9 billion vaccine facility on
Friday. The announcement comes amid global interest and demand for COVID-19
vaccines, one of which has received regulatory approval from a few
high-income countries. The Asia Pacific Vaccine Access Facility will help
the bank's low- and middle-income member countries in the procurement and
delivery of COVID-19 vaccines..." (Ravelo, 12/11).
Bloomberg: Nigeria
Plans to Approve Covid-19 Vaccine Early Next Year
"Nigeria expects to license by April one of the vaccines under
development globally for Covid-19, the West African nation's drugs
regulator said. ... Africa's most-populous country also expects to benefit
from the World Health Organization-backed Covax initiative, which is
working to improve access to vaccines for 92 low- and medium-income
countries, [National Agency for Food and Drug Administration and Control Director-General
Mojisola] Adeyeye said..." (Clowes, 12/10).
Reuters: Africa
disease control head calls on rich nations to share excess COVID-19 shots
"Countries that have ordered more COVID-19 vaccines than they need
should consider distributing excess doses to Africa, the head of the
continent's disease control body said on Thursday. ... As African countries
begin to feel the effects of a second wave of the coronavirus pandemic,
John Nkengasong, director of the Africa Centres for Disease Control and
Prevention (CDC), said it was unlikely to secure enough vaccine shots. Many
African states are relying on COVAX, a global COVID-19 vaccine allocation
plan co-led by the World Health Organization (WHO), which is working to
lower prices and discourage hoarding..." (Mohammed, 12/10).
Washington Post:
The coronavirus is ravaging the world. But life looks almost normal in much
of Africa
"...While testing has been comparatively limited, the continent
appears to have bucked the doomsday predictions of global health experts.
The telltale signs of severe outbreaks seen elsewhere -- crowded hospitals
and a spike in deaths -- have emerged in only a handful of African
countries. ... But even as more research emerges, public health experts
caution that the explanation for why Africa's caseload has remained low
will be complicated..." (Bearak/Paquette, 12/11).
Xinhua: WHO says
community involvement key to seamless launch of COVID-19 vaccine in Africa
"African governments should embark on proactive engagement with local
communities to boost uptake of COVID-19 vaccine once they are deployed in
the continent, a senior World Health Organization (WHO) official said on
Thursday. Matshidiso Moeti, WHO regional director for Africa, said that
involving communities at every stage of the vaccine's roll-out will help
dispel misinformation that could undermine inoculation of high-risk
groups..." (12/11).
U.N. News: Rich
countries' support for children 'totally inadequate': U.N. report
"The U.N. Children's Fund, UNICEF, slams the levels of financial
support for children allocated by high-income countries during the pandemic
as totally inadequate, in a child poverty report issued on Friday. The
report shows that of the $14.9 trillion spent on domestic financial
recovery packages put together by wealthier countries between February and August,
just two percent was allocated specifically to support children, and
families raising children. This is despite evidence that child poverty is
expected to remain above pre-COVID levels for at least five years in
high-income countries..." (12/10).
AP: Trump signs
order to 'rebrand' U.S. foreign assistance
"President Donald Trump has signed an order requiring that all U.S.
foreign assistance be 'rebranded' to ensure that recipients know that
American taxpayers have paid for it. Trump on Thursday directed the 22
federal agencies that distribute U.S. aid abroad to use a common logo on their
packaging. Currently, different agencies -- from the United States Agency
for International Development to the Department of Agriculture -- use
different logos on items that range from sacks of grain to medical
supplies, tents and water purification kits. That has created confusion in
some countries, according to U.S. officials who say that aid from other
nations, like China, is readily identifiable with standardized
logos..." (Lee, 12/11).
The Hill: Trump signs
executive order to brand foreign aid with common logo
"...The White House did not specify what Trump's choice of logo would
be. The executive order is among a string of actions Trump is taking in the
waning days of his presidency..." (Chalfant/Kelly, 12/10).
POLITICO: CDC's
Redfield told staff to delete email, official tells House watchdog
"Centers for Disease Control and Prevention Director Robert Redfield
instructed staff to delete an email from a Trump political appointee
seeking control over the agency's scientific reports on the pandemic, a
senior CDC official told congressional investigators this week. Redfield's
apparent instruction was revealed in a Monday closed-door interview with
the House subcommittee probing the White House's coronavirus response, which
includes the Trump administration's interference at the federal public
health agency. It came following an Aug. 8 email sent by Paul Alexander,
who was then the scientific adviser to Health and Human Services
spokesperson Michael Caputo, aiming to water down the CDC's famed Morbidity
and Mortality Weekly Reports to align with President Donald Trump's efforts
to downplay the virus.
Additional coverage of Redfield's alleged order to
delete an email is available from AP, CBS News, and Washington Post.
Devex: Global Fund
chief on COVID-19 funding, global health security
"Global COVID-19 response efforts need a bolder response, health
financing remains difficult, and the way global health security is defined
needs to change, according to Peter Sands, the executive director of the
Global Fund to Fight AIDS, Tuberculosis and Malaria. The Access to COVID-19
Tools Accelerator, or ACT Accelerator, is still short of the funding it
needs. What's needed is the 'kind of boldness of response' that wealthy
countries have shown in their domestic spending when it comes to
accelerating the development of new tools and ensuring equitable access to
them, Sands said in an interview at Devex World..." (Saldinger,
12/10).
Devex: World Bank
hopes to help get vaccines to 1 billion people, Malpass says
"Providing fair and equitable access to vaccines will be key to
managing the health and economic repercussions of the COVID-19 pandemic,
World Bank President David Malpass told Devex in an interview at Devex
World. Speaking about the efforts of the bank until now and plans for the
months to come, Malpass said the focus will be to provide vaccines to
people who don't have any other way to get them..." (Byatnal, 12/10).
Devex: Mark Green:
Next administration should address 'fragmentation' in foreign aid
"The U.S. Agency for International Development is the 'only entity' in
the U.S. government that has the capability to lead on an international
response to COVID-19, according to Mark Green, executive director at the
McCain Institute for International Leadership and former administrator at
USAID. 'We can't conquer this pandemic simply by focusing here at home.
We'll always be vulnerable. ... USAID, with its fantastic field presence,
is the only entity that I think can help get that job done,' he told Devex
Editor-in-Chief Raj Kumar at Devex World on Thursday..." (Igoe,
12/10).
Devex: Ditch the
jargon to save development, says Rory Stewart
"Development professionals must 'break out of jargon' in order to
'save this field,' according to the former U.K. secretary of state for
international development. In an interview for Devex World, Rory Stewart
said excessive jargon makes it difficult to communicate with citizens about
aid and to discuss the details of programming. 'If we are to save this
field we must break out of jargon and rhetoric and universal solutions and
theories and focus on the quality of delivery on the ground,' Stewart said
in the interview with Raj Kumar, Devex's president and
editor-in-chief..." (Worley, 12/10).
AP: Argentina's
lower house approves bill legalizing abortion
"Lawmakers in Argentina's lower house on Friday passed a bill that
would legalize elective abortions to the 14th week of pregnancy, a proposal
from President Alberto Fernández in response to long-sought demands from
women's rights activists in the homeland of Pope Francis. The bill still
needs approval from the country's Senate in a debate expected before the
end of the year..." (Calatrava, 12/11).
Additional coverage of the bill is available from AP, Foreign Policy, New York Times,
and Washington Post.
AP: Ethiopia
returns refugees who fled Tigray fighting, to alarm (Anna, 12/11).
AP: India's
pandemic recovery plan could cost air quality goals (Ghosal, 12/11).
Devex: U.S.
election marks return to 'climate responsibility,' says Paris Agreement
architect (Abrahams, 12/10).
Devex: Q&A:
Investing now in preparation for COVID-19's successor (12/11).
Forbes: A Tale Of
Two Crises And The Solutions That Bind Them: Wild Polio And COVID-19
(Sheldrick, 12/10).
New Humanitarian:
COVID-19 fuels growing conflict and displacement in Colombia (Collins,
12/10).
New York Times:
Cases Surge in South Korea, but Covid Vaccine Is Months Away (Choe, 12/10).
New York Times:
Airlines Gear Up to Transport Vaccines That Could Revive Travel (Chokshi, 12/10).
Reuters: South
Korea mobilizes military in Seoul as coronavirus cases surge, deaths rise
(Cha, 12/10).
Reuters: More
women than men in U.S. nervous about fast rollout of COVID vaccine, and
that's a problem: Reuters/Ipsos poll (Kahn/Beasley, 12/11).
Scientific American:
What Science Has Learned About the Coronavirus One Year On
(DelViscio/Glaunsinger, 12/11).
U.N. News: $1.44
billion plan to respond to Venezuela refugee and migrant needs (12/10).
U.N. News: Illicit
financial flows threaten security and stability in Africa: U.N. deputy
chief (12/10).
U.N. News: WFP
chief uses Nobel speech as call for action to avert 'hunger pandemic'
(12/10).
Xinhua: Feature:
Misusing mosquito nets threatens fight against malaria in Malawi (12/10).
Editorials and Opinions
Africa Report:
Africa: Climate change and sustainable development must be a two-way street
Oluwaseun Oguntuase, scholar at the Centre for Environmental Studies and
Sustainable Development at Lagos State University in Nigeria (12/10).
Devex: Opinion:
Does Africa need a new narrative on migration?
Maureen Achieng, chief of mission of IOM to Ethiopia and representative to
the African Union and to UNECA (12/9).
Devex: Opinion:
Judge and juror -- the U.N. system is failing the women who blow the
whistle on sexual harassment
Claudia Ahumada, global human rights lawyer, gender expert and lead of
partnerships at GENDRO, and Malayah Harper, global health and women's
rights expert, executive in residence at the Geneva Centre for Security
Policy, adviser for Fair Share of Women Leaders, founding board member and
global champion for SheDecides, and incoming director of sexual and
reproductive health and rights at EngenderHealth (12/3).
Devex: Opinion:
Beyond COVID-19 -- addressing food insecurity in Nigeria
Chioma Okafor, global health and development practitioner; Lara Aluko,
policy and program analyst; and Ibitola Asaolu, epidemiologist (12/4).
Devex: Opinion:
Why integrating mental health into UHC is key to ensuring human rights
Shekhar Saxena, visiting professor at the Harvard T.H. Chan School of
Public Health, and Elisha London, CEO and founder of United for Global
Mental Health (12/10).
New York Times:
'These Girls Are Being Cut and Married in Droves'
Stephanie Sinclair, founder and executive director of Too Young to Wed, and
Jeremiah Kipainoi, videographer (12/10).
Project Syndicate:
Supply Chains and Demand
Richard Haas, president of the Council on Foreign Relations
"...The question of how best to increase
supply-chain resilience is now front and center. Future outbreaks of
infectious diseases could prove far more disruptive [on supply chains than
COVID-19]. ... The COVID-19 crisis has revealed that interconnectedness
brings benefits as well as risks to us all. In order to address some of
these risks, supply chains will need to be rethought, with more emphasis
put on supplier diversification, domestic production, and stockpiling. The
challenge will be to strike a necessary balance ensuring that a targeted
and limited industrial policy does not become a cover for expensive
policies that threaten trade and economic growth" (12/10).
From the Global Health Policy Community
BMJ Opinion:
Covid-19 has turned the spotlight on the uneven provision of oxygen -- a
stark health inequity
Kevin Watkins, CEO of Save the Children U.K., and Adamu Isah, chief of
party for the INSPIRING Project at Save the Children Nigeria (12/11).
Brookings Institution:
The promise and peril of anti-pandemic technology
Heidi Tworek, assistant professor at the University of British Columbia and
non-resident fellow at the German Marshall Fund of the United States
(12/10).
Global Citizen:
'We Have Been Here Before': South African Health Advocate Recalls HIV/AIDS
Crisis Amid COVID-19
Jacky Habib, freelance journalist (12/10).
Human Rights Watch:
Urgently Waive Intellectual Property Rules for Vaccine (12/10).
IDSA's "Science Speaks":
COVID 19: Health workers from around the world call for recognition of,
response to pandemic's frontline toll
Antigone Barton, writer and editor of Science Speaks and editorial director
at the Infectious Diseases Society of America (12/10).
WHO: Call for
Action: Managing the Infodemic Manifesto (12/11).
World Economic Forum:
This is how we can save millions of people from extreme poverty after
COVID-19
Douglas Broom, senior writer for Formative Content (12/10).
WHO: Universal
Health Coverage Day 2020
For Universal Health Coverage Day, recognized on Dec. 12, WHO states, "This
year's UHC Day theme reminds us of our most urgent priority: Health for
All: Protect Everyone. To end this [COVID-19] crisis and build a safer and
healthier future, we must invest in health systems that protect us all --
now" (December 2020).
World Bank Blogs:
Working together in the midst of an active conflict
Carmen Nonay, practice manager at the World Bank, discusses the World
Bank's and partners' efforts to address Yemen's water supply and sanitation
needs and priorities (12/10).
From the U.S. Government
U.S. Department of State:
Vice President Pence Leads a Vaccine Distribution Roundtable
During a roundtable discussion, Vice President Pence discusses progress on
and the upcoming distribution of a COVID-19 vaccine (12/10).
USAID:
International Human Rights Day
In a statement recognizing International Human Rights Day, USAID Acting
Deputy Administrator John Barsa discusses USAID's commitment to human
rights, saying, "Promoting and protecting human rights is not only a
moral imperative, but also a critical component of America's national
security, because they are essential to any nation's self-reliance and
citizen-responsive governance. ... On International Human Rights Day, we
take a moment to express our gratitude to those who serve them on the
frontlines of the battle for basic human dignity. We continue to call for
greater humanitarian access and an end to violence against aid workers and
those who defend human rights" (12/10).
From KFF
KFF: COVID-19
Coronavirus Tracker -- Updated as of December 11, 2020
Data on country government actions in response to COVID-19 are included in
the tracker (12/11).
Additional KFF COVID-19 resources on the global
situation, as well as those focused on the response and impact within the
U.S., are available here.
|
No comments:
Post a Comment